PMID stringlengths 1 6 | sentence stringlengths 1 2.02k | embedding sequencelengths 384 384 |
|---|---|---|
1 | Formate assay in body fluids: application in methanol poisoning. | [
0.006424568593502045,
-0.056571539491415024,
-0.010271432809531689,
0.013359500095248222,
0.04379845783114433,
-0.04112891107797623,
-0.000253764825174585,
0.11216596513986588,
-0.014722554013133049,
-0.011767004616558552,
-0.05685112997889519,
-0.04580284655094147,
-0.03860853984951973,
0... |
2 | Delineation of the intimate details of the backbone conformation of pyridine nucleotide coenzymes in aqueous solution. | [
-0.06073147803544998,
-0.12620165944099426,
-0.040058430284261703,
-0.05315004661679268,
-0.005289717111736536,
0.004536285065114498,
-0.049935877323150635,
0.030709177255630493,
0.019867533817887306,
0.001385173643939197,
0.06955438107252121,
-0.0031844202894717455,
-0.05876382067799568,
... |
3 | Metal substitutions incarbonic anhydrase: a halide ion probe study. | [
-0.02166174352169037,
-0.0829588770866394,
0.003315976820886135,
0.08727777004241943,
-0.0586497001349926,
-0.01336546242237091,
0.08912328630685806,
-0.021435461938381195,
0.03993379324674606,
0.0038112320471554995,
0.031104473397135735,
-0.11511210352182388,
-0.028166208416223526,
0.0579... |
5 | Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin. | [
-0.06532704830169678,
-0.1516619622707367,
-0.020898494869470596,
0.015471466816961765,
0.054012663662433624,
-0.006382922641932964,
0.0019298042170703411,
0.08979110419750214,
0.12900987267494202,
-0.03450395166873932,
-0.004633254837244749,
-0.00579784857109189,
-0.10188178718090057,
0.0... |
4 | Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake. | [
-0.014206386171281338,
-0.08188105374574661,
-0.04639751836657524,
-0.024398023262619972,
0.06644496321678162,
0.05114559829235077,
0.020093029364943504,
0.03652812913060188,
0.0007913147564977407,
0.013060619123280048,
-0.009577153250575066,
0.006500956602394581,
0.0019542125519365072,
0.... |
6 | Studies of oxygen binding energy to hemoglobin molecule. | [
-0.004942120518535376,
-0.0009900208096951246,
-0.0736791267991066,
0.050926193594932556,
-0.018516726791858673,
-0.04191095009446144,
0.11529868096113205,
0.02613726258277893,
0.061267610639333725,
0.03843816742300987,
-0.059614166617393494,
0.004784539807587862,
-0.07777027785778046,
-0.... |
7 | Maturation of the adrenal medulla--IV. Effects of morphine. | [
0.07098941504955292,
-0.04284502565860748,
-0.003562202909961343,
0.0736338198184967,
-0.06322216242551804,
-0.004172045737504959,
-0.05630102753639221,
-0.005617157556116581,
-0.020683109760284424,
-0.03660770133137703,
0.02707015722990036,
-0.002965636318549514,
-0.04794805124402046,
0.0... |
9 | Radiochemical assay of glutathione S-epoxide transferase and its enhancement by phenobarbital in rat liver in vivo. | [
0.059765033423900604,
-0.037958744913339615,
-0.1095733717083931,
0.012677213177084923,
0.061815474182367325,
0.07505911588668823,
-0.030485164374113083,
0.10873127728700638,
-0.04257243499159813,
-0.0026421109214425087,
-0.004063989967107773,
-0.014967747963964939,
-0.01602397859096527,
0... |
8 | Comparison between procaine and isocarboxazid metabolism in vitro by a liver microsomal amidase-esterase. | [
0.06198393180966377,
-0.044079821556806564,
-0.09727436304092407,
-0.0005624789628200233,
-0.0012879138812422752,
0.02809601090848446,
-0.03090296871960163,
0.1117519661784172,
0.0013735181419178843,
0.02453174628317356,
0.04175904765725136,
-0.006378441117703915,
-0.04028549790382385,
0.0... |
10 | Digitoxin metabolism by rat liver microsomes. | [
-0.044350747019052505,
-0.0028551535215228796,
-0.04909409210085869,
0.002755572786554694,
-0.0006910230149514973,
-0.061965975910425186,
0.023302003741264343,
0.04924210160970688,
-0.021704725921154022,
-0.027430729940533638,
-0.011829450726509094,
0.014116540551185608,
-0.02296808175742626... |
11 | Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists. | [
-0.013198606669902802,
-0.020137013867497444,
-0.014106225222349167,
0.07847601920366287,
-0.06136264652013779,
0.05445455014705658,
-0.03644970804452896,
0.013928900472819805,
0.057034946978092194,
0.022054387256503105,
0.017616380006074905,
-0.02716893143951893,
0.017400501295924187,
0.1... |
13 | Action of propranolol on mitochondrial functions--effects on energized ion fluxes in the presence of valinomycin. | [
-0.026958372443914413,
-0.0273913387209177,
-0.01724531687796116,
0.04766679182648659,
0.008137806318700314,
0.0021353040356189013,
-0.04752151668071747,
0.040189508348703384,
0.09215909987688065,
0.01854119263589382,
-0.003515959484502673,
0.010714134201407433,
0.1437300145626068,
0.04761... |
12 | The effect of adrenaline and of alpha- and beta-adrenergic blocking agents on ATP concentration and on incorporation of 32Pi into ATP in rat fat cells. | [
0.032410360872745514,
0.025043057277798653,
0.008717984892427921,
0.0541977621614933,
-0.06761227548122406,
0.024206550791859627,
-0.010678412392735481,
-0.02836967445909977,
0.03283970430493355,
0.028570521622896194,
0.03907936438918114,
0.005077507346868515,
-0.03271767124533653,
-0.0007... |
14 | Malathion A and B esterases of mouse liver-I. | [
-0.0035500000230968,
-0.030530348420143127,
0.029147764667868614,
-0.030796529725193977,
0.02170347422361374,
0.07933109998703003,
0.06580653786659241,
0.020370187237858772,
0.007619930896908045,
0.032139524817466736,
0.059598106890916824,
0.011263161897659302,
-0.031776074320077896,
-0.00... |
15 | Increase in acetyl CoA synthetase activity after phenobarbital treatment. | [
-0.063997283577919,
-0.06589262187480927,
-0.034147877246141434,
0.023920273408293724,
-0.0413452573120594,
0.024531496688723564,
-0.09697606414556503,
0.07257462292909622,
0.014756670221686363,
-0.033400218933820724,
-0.0074813952669501305,
-0.057769421488046646,
-0.07722886651754379,
-0.... |
16 | Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines. | [
-0.002487585647031665,
-0.06747394800186157,
-0.15180696547031403,
-0.01428554393351078,
0.019604891538619995,
0.06257624924182892,
-0.061013393104076385,
-0.050495024770498276,
-0.00943396519869566,
0.008829962462186813,
-0.013716399669647217,
0.014248636551201344,
-0.025042518973350525,
... |
17 | Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat. | [
0.0752948671579361,
-0.06324391812086105,
0.004781246650964022,
-0.02629626914858818,
-0.05287681519985199,
0.023635471239686012,
0.048845622688531876,
-0.019728222861886024,
0.028965068981051445,
0.052459005266427994,
-0.05980389565229416,
0.01973627135157585,
-0.0717964768409729,
0.03090... |
18 | Inhibition of aldehyde reductase isoenzymes in human and rat brain. | [
0.02796226181089878,
-0.06333550810813904,
-0.10125569254159927,
0.07639265805482864,
-0.016319414600729942,
0.06608383357524872,
-0.014790808781981468,
-0.08294078707695007,
0.02368166297674179,
-0.03462504968047142,
0.018713321536779404,
0.027560295537114143,
-0.030276618897914886,
0.013... |
19 | Antidepressant drugs affect dopamine uptake. | [
0.04289991408586502,
-0.01740928739309311,
0.005606120452284813,
0.038516007363796234,
-0.0004472403961699456,
-0.0006450689397752285,
0.05036327987909317,
0.11917086690664291,
0.04744585603475571,
-0.004791370127350092,
-0.09408178925514221,
0.047133393585681915,
0.01716390997171402,
0.02... |
20 | Aggregation of blood platelets by adrenaline and its uptake. | [
0.012715574353933334,
-0.0036378412041813135,
-0.03972766175866127,
0.03988100588321686,
-0.03572637960314751,
0.024293188005685806,
0.027310075238347054,
0.10524522513151169,
0.07746459543704987,
-0.039547599852085114,
-0.011726717464625835,
-0.012956609018146992,
-0.05614650249481201,
-0... |
21 | (--)-alpha-Bisabolol has a primary antipeptic action depending on dosage, which is not caused by an alteration of the pH-value. | [
0.04608557000756264,
-0.03867556154727936,
-0.04100145027041435,
0.009260238148272038,
0.019219081848859787,
-0.014112989418208599,
0.06121709197759628,
0.06805924326181412,
0.10394817590713501,
-0.007969483733177185,
0.025086795911192894,
-0.01622983254492283,
0.04592239484190941,
0.06019... |
21 | The proteolytic activity of pepsin is reduced by 50 percent through addition of bisabolol in the ratio of 1/0.5. | [
0.03965887054800987,
-0.07856971025466919,
-0.08119326829910278,
0.039564911276102066,
0.038410115987062454,
0.04851287975907326,
0.0755208432674408,
0.08388306200504303,
0.07241456210613251,
-0.023340605199337006,
-0.010446031577885151,
-0.040833134204149246,
0.0025530278217047453,
0.0832... |
21 | The antipeptic action of bisabolol only occurs in case of direct contact. | [
0.006336580961942673,
-0.04233397915959358,
0.004144203849136829,
0.04268103092908859,
0.006925939582288265,
-0.018745405599474907,
0.08995646238327026,
0.07428846508264542,
0.1365407407283783,
0.016256045550107956,
0.002488917438313365,
-0.04631151631474495,
0.06331489235162735,
0.0505639... |
21 | In case of a previous contact with the substrate, the inhibiting effect is lost. | [
-0.0382944755256176,
-0.029860110953450203,
0.08780379593372345,
0.06331484764814377,
0.050361890345811844,
-0.012459781020879745,
0.029933573678135872,
0.07911642640829086,
0.06141519173979759,
-0.029322883114218712,
0.09253595024347305,
0.04309605062007904,
-0.0030834360513836145,
0.0607... |
End of preview. Expand
in Data Studio
No dataset card yet
- Downloads last month
- 47